Menatetrenone (Vitamin K2) and Bone Quality in the Treatment of Postmenopausal Osteoporosis

Menatetrenone (vitamin K2) reduces the incidence of vertebral fractures but has only modest effects on bone mineral density (BMD) in postmenopausal women with osteoporosis. Combined tr...

Share this with your friends
AttachmentSize
Menatetrenone (Vitamin K2) and Bone Quality in the Treatment of Postmenopausal Osteoporosis.pdf174.56 KB